Yin S - Search Results

1

Maspin reprograms the gene expression profile of prostate carcinoma cells for differentiation.

Bernardo MM, Meng Y, Lockett J, Dyson G, Dombkowski A, Kaplun A, Li X, Yin S, Dzinic S, Olive M, Dean I, Krass D, Moin K, Bonfil RD, Cher M, Sakr W, Sheng S. Bernardo MM, et al. Among authors: yin s. Genes Cancer. 2011 Nov;2(11):1009-22. doi: 10.1177/1947601912440170. Genes Cancer. 2011. PMID: 22737267 Free PMC article.

2

Endogenous inhibition of histone deacetylase 1 by tumor-suppressive maspin.

Li X, Yin S, Meng Y, Sakr W, Sheng S. Li X, et al. Among authors: yin s. Cancer Res. 2006 Sep 15;66(18):9323-9. doi: 10.1158/0008-5472.CAN-06-1578. Cancer Res. 2006. PMID: 16982778

3

Bax mediates the apoptosis-sensitizing effect of maspin.

Liu J, Yin S, Reddy N, Spencer C, Sheng S. Liu J, et al. Among authors: yin s. Cancer Res. 2004 Mar 1;64(5):1703-11. doi: 10.1158/0008-5472.can-03-2568. Cancer Res. 2004. PMID: 14996730

4

Tumor-suppressive maspin regulates cell response to oxidative stress by direct interaction with glutathione S-transferase.

Yin S, Li X, Meng Y, Finley RL Jr, Sakr W, Yang H, Reddy N, Sheng S. Yin S, et al. J Biol Chem. 2005 Oct 14;280(41):34985-96. doi: 10.1074/jbc.M503522200. Epub 2005 Jul 26. J Biol Chem. 2005. PMID: 16049007 Free article.

5

Tumor suppressive maspin and epithelial homeostasis.

Lockett J, Yin S, Li X, Meng Y, Sheng S. Lockett J, et al. Among authors: yin s. J Cell Biochem. 2006 Mar 1;97(4):651-60. doi: 10.1002/jcb.20721. J Cell Biochem. 2006. PMID: 16329135 Review.

6

Maspin retards cell detachment via a novel interaction with the urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor system.

Yin S, Lockett J, Meng Y, Biliran H Jr, Blouse GE, Li X, Reddy N, Zhao Z, Lin X, Anagli J, Cher ML, Sheng S. Yin S, et al. Cancer Res. 2006 Apr 15;66(8):4173-81. doi: 10.1158/0008-5472.CAN-05-3514. Cancer Res. 2006. PMID: 16618739

7

Maspin augments proteasome inhibitor-induced apoptosis in prostate cancer cells.

Li X, Chen D, Yin S, Meng Y, Yang H, Landis-Piwowar KR, Li Y, Sarkar FH, Reddy GP, Dou QP, Sheng S. Li X, et al. Among authors: yin s. J Cell Physiol. 2007 Aug;212(2):298-306. doi: 10.1002/jcp.21102. J Cell Physiol. 2007. PMID: 17458898

8

Tumor-initiating cells and FZD8 play a major role in drug resistance in triple-negative breast cancer.

Yin S, Xu L, Bonfil RD, Banerjee S, Sarkar FH, Sethi S, Reddy KB. Yin S, et al. Mol Cancer Ther. 2013 Apr;12(4):491-8. doi: 10.1158/1535-7163.MCT-12-1090. Epub 2013 Feb 27. Mol Cancer Ther. 2013. PMID: 23445611 Free PMC article.

9

Functional role of miR-10b in tamoxifen resistance of ER-positive breast cancer cells through down-regulation of HDAC4.

Ahmad A, Ginnebaugh KR, Yin S, Bollig-Fischer A, Reddy KB, Sarkar FH. Ahmad A, et al. Among authors: yin s. BMC Cancer. 2015 Jul 24;15:540. doi: 10.1186/s12885-015-1561-x. BMC Cancer. 2015. PMID: 26206152 Free PMC article.

10

Enhanced anticancer effect of the combination of cisplatin and TRAIL in triple-negative breast tumor cells.

Xu L, Yin S, Banerjee S, Sarkar F, Reddy KB. Xu L, et al. Among authors: yin s. Mol Cancer Ther. 2011 Mar;10(3):550-7. doi: 10.1158/1535-7163.MCT-10-0571. Epub 2011 Jan 20. Mol Cancer Ther. 2011. PMID: 21252285 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,634 results

Search Page

Filters